Evidence map›Paper›PMID 38941965›Full record

ArticleEmerging infectious diseases2024

Emergence of Bluetongue Virus Serotype 3, the Netherlands, September 2023.

Melle Holwerda, Inge M G A Santman-Berends, Frank Harders, Marc Engelsma, Rianka P M Vloet, Eveline Dijkstra, Rene G P van Gennip, Maria H Mars, Marcel Spierenburg, Lotte Roos and 2 more

Abstract readHistorical Article
In one paragraph

Article in Emerging infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Melle Holwerda
Inge M G A Santman-Berends
Frank Harders
Marc Engelsma
Rianka P M Vloet
Eveline Dijkstra
Rene G P van Gennip
Maria H Mars
Marcel Spierenburg
Lotte Roos
René van den Brom
Piet A van Rijn

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since 1998, notifiable bluetongue virus (BTV) serotypes 1-4, 6, 8, 9, 11, and 16 have been reported in Europe. In August 2006, a bluetongue (BT) outbreak caused by BTV serotype 8 began in northwestern Europe. The Netherlands was declared BT-free in February 2012, and annual monitoring continued. On September 3, 2023, typical BT clinical manifestations in sheep were notified to the Netherlands Food and Product Safety Consumer Authority. On September 6, we confirmed BTV infection through laboratory diagnosis; notifications of clinical signs in cattle were also reported. We determined the virus was serotype 3 by whole-genome sequencing. Retrospective analysis did not reveal BTV circulation earlier than September. The virus source and introduction route into the Netherlands remains unknown. Continuous monitoring and molecular diagnostic testing of livestock will be needed to determine virus spread, and new prevention strategies will be required to prevent BTV circulation within the Netherlands and Europe.

Indexed as

BluetongueBluetongue virusSerogroupAnimalsCattleCommunicable Diseases, EmergingDisease OutbreaksHistory, 21st CenturyNetherlandsPhylogenyRetrospective StudiesSheepbluetonguebluetongue viruscattlegenotypingserotypingsheepthe Netherlandsvector-borne infectionsviruseszoonoses

Identifiers

PMID38941965
PMCPMC11286052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.